Cost-Effectiveness of Denosumab vs. Brand or Generic zoledronic Acid in Patients with Breast Cancer in Kazakhstan
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.332
https://www.valueinhealthjournal.com/article/S1098-3015(14)02262-1/fulltext
Title :
Cost-Effectiveness of Denosumab vs. Brand or Generic zoledronic Acid in Patients with Breast Cancer in Kazakhstan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02262-1&doi=10.1016/j.jval.2014.08.332
First page :
A773
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2327